$113.06 +0.40 (0.36%) Celgene Corp - NASDAQ

Dec. 8, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 113.06
Trade Time: Dec 08 04:00 PM Eastern Daylight Time
Change: +0.40 (0.36%)
Prev Close: 112.66
Open: 112.58
Bid: 113.06
Ask: 113.07
  1. Actelion Remains In M&A Spotlight, ASH Data In Focus

    TalkMarkets | Dec. 7, 2016 | 18:01PM EST
  2. S&P 500, Dow Notch All-Time Highs; Dave & Buster's Soars 19%

    Investors Business Daily | Dec. 7, 2016 | 16:07PM EST
  3. Stock Indexes Extend Gains, But Big R&D Biotechs Dive

    Investors Business Daily | Dec. 7, 2016 | 14:04PM EST
  4. Juno Therapeutics (JUNO) Shows Positive Early Data In Leukemia Patients

    TalkMarkets | Dec. 5, 2016 | 09:21AM EST
  5. Bluebird Rockets On Myeloma Drug; Celgene Gets Boost

    Investors Business Daily | Dec. 1, 2016 | 12:10PM EST
  6. Bluebird Bio, Celgene Multiple Myeloma Therapy Shines In 9-Patient Study

    Investors Business Daily | Nov. 30, 2016 | 18:58PM EST
  7. Market Reversal In Biotech But Healthcare Stocks Are Still Muddled

    TalkMarkets | Nov. 29, 2016 | 22:56PM EST
  8. Calithera In Focus, Part 2 - Upcoming Catalysts In TNBC And RCC

    TalkMarkets | Nov. 23, 2016 | 11:45AM EST
  9. Rayno Biobeat #4: Sector Shift Underway But What’s Next For Biotech?

    TalkMarkets | Nov. 23, 2016 | 00:13AM EST
  10. Rayno Biobeat #3…Trump Biotech Rally Leads Market Up

    TalkMarkets | Nov. 9, 2016 | 23:23PM EST
  11. Rayno Biobeat #2…Good Value in Large Cap Biopharmaceuticals

    TalkMarkets | Nov. 7, 2016 | 10:20AM EST
  12. Before The Move: Stocks To Own If Trump Wins

    TalkMarkets | Nov. 6, 2016 | 16:47PM EST
  13. Fundamentals Remain Strong In The Pharma Sector

    TalkMarkets | Nov. 5, 2016 | 18:49PM EST
  14. When Is The PEG Ratio Superior to the P/E Ratio? Part 2

    TalkMarkets | Nov. 4, 2016 | 06:48AM EST
  15. Biotech Meltdown: Financial Metrics Offer Few Clues For What is Next

    TalkMarkets | Nov. 1, 2016 | 06:52AM EST
Trading Center